Ameriprise Financial Inc Tango Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.93 - $11.26 $112,933 - $434,005	-38,544 Reduced 75.19%	12,715 $143,000
Q2 2023 Aug 14, 2023	SELL	$2.67 - $4.7 $3,163 - $5,569	-1,185 Reduced 2.26%	51,259 $170,000
Q1 2023 May 15, 2023	BUY	$3.76 - $8.06 $91,871 - $196,938	24,434 Added 87.23%	52,444 $207,000
Q4 2022 Feb 14, 2023	BUY	$3.41 - $8.29 $34 - $82	10 Added 0.04%	28,010 $203,000
Q3 2022 Nov 14, 2022	BUY	$3.25 - $5.46 $91,000 - $152,880	28,000 New	28,000 $101,000

123

91.7M

3.1K

1.5K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $268M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.